Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02312492 · ClinicalTrials.gov registry record · NA
Development of a Novel Method to Study in Vivo Fatty Acid Metabolism Using Stable Isotope Labeled Fatty Acids in Humans
A NA study of Dyslipidemia, sponsored by Tufts University.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT02312492: Completed NA study of Dyslipidemia, sponsored by Tufts University.
NCT02312492 is a NA study of Dyslipidemia that has completed, run by Tufts University. The registered enrollment target is 6 participants, below the 363-participant average among 40 other Dyslipidemia trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02312492, a NA study of Dyslipidemia, has completed, sponsored by Tufts University.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
Specific Aim 1: To compare the metabolic fate (transport, conversion and oxidation) of labeled 18:0 (13C18:0) and its metabolic product 18:1 (13C18:1) in the fed state after habituation to diets enriched in the corresponding fatty acid. Hypothesis: In the fed state, the metabolic fate of 13C18:0 compared to 13C18:1 will be characterized by similar transport, higher conversion, and similar oxidation rates..
Primary Outcome
measurement of isotope ratio (13C:12C) in total plasma, cholesterol ester, triglyceride, phospholipid, monoglyceride and diglyceride subfractions as well as chylomicrons, VLDL (very low density lipoprotein), TRL (triglyceride-rich lipoprotein), LDL (low density lipoprotein) and HDL (high density lipoprotein).
Conditions Studied
Interventions
- OTHER Oleic Diet
- OTHER Palmitic Diet
- OTHER Stearic Diet
Study Locations (1)
Massachusetts
- Jean Mayer Human Nutrition Research Center on Aging - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2013-01 |
| Est. Completion | 2018-12 |
| Phase | NA |
What the finished NCT02312492 record still lists
NCT02312492 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 363-participant average among 40 other Dyslipidemia trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Dyslipidemia appearing as the primary indexed condition, and to 3 interventions - of which Oleic Diet is the first listed.
NCT02312492 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02312492 about?
NCT02312492 is a clinical study titled "Development of a Novel Method to Study in Vivo Fatty Acid Metabolism Using Stable Isotope Labeled Fatty Acids in Humans". Specific Aim 1: To compare the metabolic fate (transport, conversion and oxidation) of labeled 18:0 (13C18:0) and its metabolic product 18:1 (13C18:1) in the fed state after habituation to diets enriched in the corresponding fatty acid. Hypothesis: In the fed state, the metabolic fate of 13C18:0 co...
What is the current status of trial NCT02312492?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2013-01. Estimated completion is 2018-12.
What conditions does trial NCT02312492 study?
This clinical trial studies the following conditions: Dyslipidemia.
What interventions are being tested in trial NCT02312492?
The interventions under investigation include: Oleic Diet (OTHER), Palmitic Diet (OTHER), Stearic Diet (OTHER).
Who is sponsoring clinical trial NCT02312492?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02312492 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dyslipidemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02312492's enrollment target sits among peer trials
6 41st of 40 the lowest of 40 other Dyslipidemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dyslipidemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Cottonseed Oil Versus Matched PUFA Effects
RECRUITING · NA
-
Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults
RECRUITING · NA
-
A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors
RECRUITING · NA
-
Intermittent Cottonseed Oil Consumption
RECRUITING · NA
-
Change of Fructose to Fat in South Asians
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia